NCT05968430: Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
- State
- Under way
- Phase
- Phase 3
- People
- 1,076 taking part
- Started
- 14 Jul 2023
- Primary completion
- 30 Dec 2025
- Arms
- RTW Substudy
- Results
- None posted
- 14 Jul 2023: Trial started
- 1 Aug 2023: Trial registered